FAQ
Log In
Sunday 21st April 2019

News

FT Health

A disaster is unfolding in the antibiotics market

There is no viable path for new drugs, however valuable they are to society

Revamp at Silence does little to improve investors’ wellbeing

Biotech group has changed management team and reviewed its corporate strategy

FT Health: Foreign aid and the threat to multilateralism

Measles spiking, commercial influences on health, zombie pigs

Big pharma’s billion-dollar bets

Why large drug companies risk billions to fund their next blockbuster

Crunched: are men to blame for the infertility crisis?

The FT digs into the data for the truth about the fertility 'cliff-edge'

Roche raises 2019 outlook on strong first quarter

Johnson & Johnson earnings hit by lawsuit costs

World’s largest healthcare group lifts guidance despite litigation worries

NHS hands doctors cash top-ups to halt early retirements

Bid to stave off staff shortages as consultants face hefty pensions tax bills

Purdue tried to buy Reckitt’s addiction business

Opioid maker sought drug group that treats abuse of its own painkillers

New York grapples with measles outbreak

False rumours and anti-government sentiment spur resurgence of infectious disease

Fisher-Price recalls baby sleeper linked to over 30 deaths

Consumer Product Safety Commission warns parents to stop using Rock ‘n Play product

Data on new mothers and babies sold to third parties

Baby ‘goody bag’ provider Bounty fined for sharing records gleaned on NHS wards

Bristol-Myers shareholders approve $90bn Celgene takeover

FT Health: The struggle for women’s rights

World population report, Unicef’s Henrietta Fore, astronaut twins

I was misdiagnosed with Alzheimer’s disease

Tackling the similar but treatable ‘normal pressure hydrocephalus’ would advance public health

Evofem Biosciences raises $80m for new contraceptive

US group seeks regulatory approval for first ‘game-changing’ product in two decades

South Korean court rules abortion ban ‘unconstitutional’

Decision will give women the right to choose for the first time since 1953

Is Amazon the undoing of Tesco? Or is Tesco doing an Amazon?

Grocer’s emphasis on loyalty scheme and app mirrors US giant’s ways

Indivior indictment casts cloud over Reckitt Benckiser

Consumer goods giant sheds £3bn in market value over potential exposure to opioid charges

The Theranos scandal has not spooked med-tech investors

Start-ups are developing self-diagnostic technology with the help of smartphones

Indivior hit by charge it illegally marketed opioid addiction drug

UK-listed drugmaker vows to contest allegations as shares fall more than 70%

UK stem-cell specialist ReNeuron agrees China deal

Fosun Pharma to fund the development of eye disease and stroke therapy programmes

Pharmacy benefit managers face bipartisan criticism

Republican and Democratic senators accuse industry intermediaries of harming consumers

Alcon/Novartis: eye inflection

The Swiss pharma group’s former subsidiary will fare better alone

Novartis to limit M&A spend to 5% of market value

Chief Vas Narasimhan looks to ‘drive more value for shareholders’ with focused deals

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019